When a narrative is not yet well understood and lacks clear large cap leaders for benchmarking, fomo and speculation take over. Capital turns more aggressive while uncertainty around ceilings and valuation frameworks makes pricing these assets inefficient. That’s how the AI meta started before producing billion dollar runners.


Same conditions could easily repeat here.
DeSci x Biotech x Peptides
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments